Report on hearing loss in oncology

Christiane Schultz1, Maria Valéria Schmidt Goffi-Gomez, Patrícia Helena Pecora Liberman

  • 1Audiology Sector, Hospital do Câncer A C Camargo.

Summary

Current hearing loss criteria are inadequate for identifying cisplatin-induced ototoxicity in cancer patients. Further research is needed to improve patient quality of life by better understanding chemotherapy-related hearing loss.